Connect with us

Health

Adolescent TB Patients Suffer Fatal Neglect—Doctors

Published

on

As a group of Khayelitsha schoolchildren living with drug-resistant tuberculosis (DR-TB) today unveiled an artwork commemorating their battles against the disease, the international humanitarian organisation, Doctors Without Borders (MSF), has warned that adolescents are being fatally neglected in the response to TB and DR-TB in South Africa, and calls on the Department of Basic Education (DBE) to expedite plans to implement school-based TB education and TB screening in collaboration with the Department of Health (DOH).

Medical staff who work in the MSF DR-TB projects in Khayelitsha, Western Cape, and King Cetshwayo District, KwaZulu-Natal, have spoken of critical gaps in the country’s response, including low TB literacy, too few TB screening opportunities, difficulties identifying adolescents who have been exposed to DR-TB and linking them to diagnosis, and limited access to better, more tolerable DR-TB treatments. Consequently this underdiagnosed population misses the opportunity to realise improved treatment outcomes.

According to Dr Jenny Hughes, MSF’s TB doctor in Khayelitsha, ‘an estimated 10 percent (of approximately 650’000 cases of DR-TB worldwide) occur among children and adolescents, and although young people respond well to treatment, thousands die from this disease each year, largely due to lack of access to improved diagnostic techniques and more tolerable treatment for young people. South Africa is no exception.’

The country’s new National Strategic Plan for HIV, TB and STIs (2017-2022) recommends providing health services such as TB screening in schools, although this much-needed activity is likely to stall until the Department of Basic Education finalizes and implements its 2015 Draft Policy on HIV, STIs and TB. MSF calls on the DBE to have this strategy approved without further delay.

After-hours strategies are also required for tracing adolescents who have been in contact with TB and DR-TB patients, and linking them to diagnostic and treatment services. Upward of 50% of all DR-TB cases in Khayelitsha are due to direct transmission of already drug-resistant strains. In South Africa, a strategic focus on tracing children under age 5 may have led to other vulnerable populations being neglected, including adolescents.

“Adolescents are usually at school during the daytime when health department officials do TB screening in households. Those who do get screened and referred to clinics for diagnosis find queues that keep them out of school for hours, so many turn away. So on the one hand we need wider screening for TB in schools, and on the other we need youth-friendly facilities with after-hours services,” says Xoliswa Harmans, a DR-TB counsellor at MSF Khayelitsha.

17 year old Sinethemba Kuse was diagnosed late, just days before Christmas in 2015, and later found that her TB strain was drug resistant (DR-TB).

“I didn’t know about TB. Nobody ever talked about it in school and I didn’t know that I could go to my local clinic to have a TB screening,” says Kuse, who is the subject of the portrait that will be unveiled on World TB Day.

Once diagnosed with DR-TB adolescents must face the same harsh treatment regimen that is used for adults, which includes a painful daily injection for months and side effects of the medications that can have catastrophic consequences for their growth and development.

“Studies conducted in the Western Cape show that up to 24% of children and adolescents on the injectable DR-TB agent that is currently in standard use develops hearing loss, which obviously impacts everything from schoolwork to social life. More tolerable treatments substituting an injectable agent with promising new medicines like delamanid are urgently required in order to make treatment more tolerable and also improve adolescent treatment outcomes,’ says Dr Hughes.

On World TB Day MSF will join a list of signatories on an open letter to delamanid manufacturer Otsuka, calling on the Japanese pharmaceutical company to urgently make this important new drug more widely available.

Kuse is one of the first South Africans under the age of 18 to have been initiated on delamanid, which is currently only available to approximately 1% of those in need of the drug. She is doing very well and her doctors expect she will be cured this year. Kuse says she agreed to sit for the portrait because she wants other youth to know that TB can be cured. Prints of the 2m tall artwork will be presented to select clinics and schools in Khayelitsha, along with Kuse’s story. The piece was created by local artist Claude Chandler, using word stamps made by Kuse and other adolescent DR-TB patients. The patients were asked to think of a word that expressed their experience of living with DR-TB. Kuse’s word was ‘hope’.

Modupe Gbadeyanka is a fast-rising journalist with Business Post Nigeria. Her passion for journalism is amazing. She is willing to learn more with a view to becoming one of the best pen-pushers in Nigeria. Her role models are the duo of CNN's Richard Quest and Christiane Amanpour.

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Jacaranda Gets Funds to Expand Affordable Maternal Healthcare in Kenya

Published

on

Jacaranda Maternity

By Modupe Gbadeyanka

To expand affordable healthcare in Kenya, Swedfund has invested about $600,000 into Jacaranda Health Limited (Jacaranda Maternity) to support innovations in neonatal intensive care and strengthen Jacaranda’s ability to provide life-saving services to underserved populations.

Jacaranda Maternity provides high-quality maternal health care at more affordable pricing than typical private providers, focusing on women in Nairobi’s low- and middle-income communities.

The new funding will support the opening of new hospitals, upgrading of neonatal care, and improvements to existing facilities.

Maternal and newborn health outcomes in Kenya remain a challenge, with maternal mortality still high despite improvements in skilled birth attendance.

Public health facilities play a central role but face capacity constraints, while access to reliable, quality care varies across regions and income groups.

Private healthcare providers offering essential maternity services at accessible price points can complement public provision.

Jacaranda Maternity aims to expand its network to six hospitals to achieve financial sustainability while scaling its impact. The healthcare provider is a recognised leader in promoting women’s health, with 71 percent of its staff being women, and a track record of effective environmental and social management.

“This investment will help Jacaranda Maternity provide life-saving care to more women and families while furthering Swedfund’s mission to promote inclusive and sustainable healthcare,” a Senior Investment Manager at Swedfund, Audrey Obara, said.

Continue Reading

Health

Nigeria Secures $350,000 FAO Support to Tackle Rising Bird Flu

Published

on

bird flu

By Adedapo Adesanya

Nigeria will get a $350,000 intervention from the Food and Agriculture Organisation of the United Nations (FAO) to support its response to the ongoing outbreak of Highly Pathogenic Avian Influenza (bird flu) and strengthen the country’s animal health systems.

An agreement was reached on Wednesday during a strategic meeting between the Minister of Livestock Development, Mr Idi Mukhtar Maiha, and the FAO Representative to Nigeria and the Economic Community of West African States, Mr Hussein Gadain, in Abuja.

The intervention, approved under FAO’s Technical Cooperation Programme, will support disease containment efforts in 11 affected states and enhance surveillance, coordination and response mechanisms to prevent further spread of the disease.

Speaking during the meeting, Maiha said effective disease control remains critical to improving livestock productivity and protecting the livelihoods of farmers across the country.

He explained that factors such as drought, scarcity of feed, interaction between livestock and wildlife, as well as cross-border movement of animals have contributed to the spread of diseases in some areas.

“We must continue to strengthen our animal health systems and build the capacity required to respond effectively to disease outbreaks. Our collaboration with FAO will help protect livestock assets, improve productivity and support the broader transformation of the sector,” the minister said.

Mr Gadain commended the federal government’s commitment to the development of the livestock sector and assured that FAO would continue to provide technical support to Nigeria.

He stressed the need to strengthen veterinary services at the state and community levels, improve early detection of diseases and promote biosecurity practices among livestock farmers.

The meeting also reviewed progress on the global campaign to eradicate Peste des Petits Ruminants, a highly contagious disease that affects sheep and goats.

To advance the initiative, the ministry plans to convene a national technical meeting involving veterinary institutions, researchers and practitioners to review Nigeria’s eradication strategy and address gaps in vaccine supply.

As part of preparations, the ministry will engage the National Veterinary Research Institute to assess its vaccine production capacity while exploring other options for vaccine procurement to meet national demand.

Both parties also agreed to accelerate Nigeria’s access to financing under the Pandemic Fund through the One Health approach in collaboration with the Nigeria Centre for Disease Control and the Federal Ministry of Health to strengthen preparedness and response to zoonotic diseases.

Plans are also underway for the Director-General of FAO to participate in the Antimicrobial Resistance Conference scheduled for June 2026 in Abuja, where President Bola Tinubu is expected to be recognised as the African Champion for the eradication of Peste des Petits Ruminants.

The meeting further agreed to inaugurate a Livestock Donor Working Group to coordinate development partner support and advance key initiatives, including the development of a national feed and fodder strategy aimed at improving productivity and sustainability in the livestock sector.

Continue Reading

Health

Chimamanda: Euracare Raises Concerns Over MDCN Investigation Panel Process

Published

on

Euracare

By Aduragbemi Omiyale

A Lagos-based healthcare facility currently in the limelight, Euracare Multi-Specialist Hospital, has faulted the outcome of the investigation panel of the Medical and Dental Council of Nigeria (MDCN) on the death of a 21-month-old Nkanu Nnamdi Esege, son of a renowned author, Chimamanda Ngozi Adichie.

The toddler died some weeks ago after an alleged overdose of sedative propofol, with the family alleging medical negligence.

This week, the panel suspended the two doctors of Euracare, Dr Tosin Majekodunmi and Dr Titus Ogundare.

Reacting to the development in a statement, the hospital claimed it observed “a number of serious concerns that have arisen in the course of these proceedings.”

In the statement made available to Business Post, Euracare emphasised that it vouches for the “professionalism and integrity of our clinical team,” pointing out that “certain established processes and protocols have not been followed in the manner required” during the probe.

While it empathised “with the family of Master Nkanu Nnamdi Esege” over the unfortunate incident, the healthcare firm said there was a “serious breach” by the investigators that “cannot go unaddressed.”

It identified this breach as the disclosure of “matters covered by patient and institutional confidentiality” outside the appropriate channels.

Below is the full statement from Euracare;

Our attention has been drawn to widespread media reports concerning the interim suspension orders and other findings issued by the Medical and Dental Practitioners Investigation Panel against thirteen doctors, two of whom are our clinical staff members in connection with the ongoing proceedings relating to the death of Master Nkanu Nnamdi Esege. We remain fully committed to cooperating with all relevant regulatory and judicial authorities in the course of their inquiries.

We however wish to place on record our confidence in the professionalism and integrity of our clinical team. Dr. Tosin Majekodunmi and Dr. Titus Ogundare who are experienced professionals whose records of service to patients in Nigeria span many years. Both doctors have, in their respective careers, contributed meaningfully to the delivery of quality healthcare to Nigerian patients at a standard comparable to what is obtainable in the world’s leading medical facilities.

In the interest of transparency, since the commencement of this matter, we have conducted a thorough internal review of the clinical events in question, in line with our clinical governance standards and best practices. We have actively demonstrated our commitment to transparency and will continue to engage openly with all inquiries directed at us.

We are also compelled to draw attention to a number of serious concerns that have arisen in the course of these proceedings. It is our position that certain established processes and protocols have not been followed in the manner required. We have further noted, with deep concern, that matters covered by patient and institutional confidentiality appear to have been disclosed outside the appropriate channels, and we consider this a serious breach that cannot go unaddressed.

We wish to state that we stand by the principles of equality, fairness, and good governance. Every party in this matter, including our institution and our staff, is entitled to a process that is conducted with rigour, impartiality, and respect for the rules that govern it. We will be raising these concerns through the appropriate legal and regulatory channels.

We continue to empathize with the family of Master Nkanu Nnamdi Esege. The loss of a child is a grief without measure, and we carry that awareness in everything we say and do in relation to this matter.

Continue Reading

Trending